{"database": "lobbying", "table": "lobbying_activities", "rows": [[2189911, "d8380637-79d6-4e86-999a-ec8ea76801eb", "Q3", "RUBICON ADVISORS, LLC", 315091, "DYNAVAX TECHNOLOGIES", 2018, "third_quarter", "PHA", "Prescription Drug User Fee", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2018-10-18T09:49:01.607000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2189911"], "units": {}, "query_ms": 144.3459689617157, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}